Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05641662 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Exergaming to Reduce Sedentary Time in Inactive Patients With Heart Failure

Study acronym: Heart-eXg
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 10 to 12 Primary completion date: Aug 16, 2026 to Dec 31, 2026 · Completion date: Apr 30, 2027 to Jul 30, 2027v4 Show 2 more changesShow less
    • Primary completion date: Aug 16, 2026 to Dec 31, 2026
    • Completion date: Apr 30, 2027 to Jul 30, 2027
  2. Study sites: 5 to 10 Eligibility criteria shortened, about 5 wordsv3 Show 1 more changeShow less
    • Eligibility criteria shortened, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  3. Primary completion date: Aug 16, 2023 to Aug 16, 2026 Study sites: 1 to 5 · Completion date: Apr 30, 2026 to Apr 30, 2027 · Secondary endpoints: details revised at 1 of 6 entriesv2 Show 3 more changesShow less
    • Study sites: 1 to 5
    • Completion date: Apr 30, 2026 to Apr 30, 2027
    • Secondary endpoints: details revised at 1 of 6 entries
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this to determine the effect of tailored exergaming for inactive patients with heart failure to reduce their sedentary time, improve their daily physical activity, exercise capacity, decrease frailty and improve health-related quality of life. Participants will, on a background of standard guideline-directed medical therapy patients, be randomised to tailored activity advice (control) or the Heart-Exergame (Heart-eXg) intervention for a period of 3 months. Patients randomised to the Heart-eXg group will receive an exergame with feedback and tailoring to adapt the exergaming advice. Patients will also be able to play with a person in their own network.
Trial Details
NCT Number NCT05641662
Lead Sponsor Linkoeping University
Conditions Cardiovascular Diseases
Enrollment 750 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov